Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
Condition: Juvenile Idiopathic Arthritis Interventions: Drug: Upadacitinib; Drug: Tocilizumab Sponsor: AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2022 Category: Research Source Type: clinical trials
Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS)
Condition: Severe Fever With Thrombocytopenia Syndrome Interventions: Drug: Methylprednisolone; Drug: intravenous immunoglobulin; Drug: Tocilizumab; Drug: Low molecular weight heparin; Other: standard treatment Sponsor: Qin Ning Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2022 Category: Research Source Type: clinical trials
